Stay updated on Atezo & Tiragolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Atezo & Tiragolumab in NSCLC Clinical Trial page.

Latest updates to the Atezo & Tiragolumab in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedOn the page footer, the history shows an addition of Revision: v3.3.3 and removals of HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe history now shows a new Revision: v3.3.2 and the removal of v3.2.0, indicating a backend version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedThe government funding status notice banner has been removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check63 days agoChange DetectedNo substantive changes were detected; the page structure and version history appear the same, To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedUpdate includes a funding/status notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference11%

- Check99 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.3%

Stay in the know with updates to Atezo & Tiragolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezo & Tiragolumab in NSCLC Clinical Trial page.